REFERENCES
- Gueron M, Ilia R, Sofer S. The cardiovascular system after scorpion envenomation. A review. J Toxicol Clin Toxicol 1992; 30: 245–258
- Abroug F, Nouira S, Haguiga H, et al. A randomised clinical trial of high-dose hydrocortisone hemisuccinate in scorpion envenomation. Ann Emerg Med 1997; 30: 245–258
- Ismail M. The scorpion envenoming syndrome. Toxicon 1995; 33: 825–858
- Ismail M, Fatani A J, Dabees T T. Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein-kinin inhibitors. Toxicon 1992; 30: 1257–1279
- Bond G R. Antivenin administration for centruroïdes scorpion sting: Risks and benefits. Ann Emerg Med 1992; 21: 788–791
- Muller G J. Scorpionism in South Africa. A report of 42 serious scorpion envenomations. S Afr Med J 1993; 83: 405–411
- el-Amin E O, Sultan O M, al-Magamci A I, Elidrissy A. Serotherapy in the management of scorpion sting in children in Saudi Arabia. Ann Trop Paediatr 1994; 14: 21–24
- Gateau T, Bloom M, Clark R. Response to specific Centruroïdes sculpturatus antivenom in 151 cases of scorpion stings. J Toxicol Clin Toxicol 1994; 32: 165–171
- Dehesa-Davila M, Possani L D. Scorpionism and serotherapy in Mexico. Toxicon 1994; 32: 1015–1018
- Freire-Maia L, Campos J A, Amaral C F. Approaches to the treatment of scorpion envenoming. Toxicon 1994; 32: 1009–1014
- Ismail M. The treatment of the scorpion envenoming syndrome: The Saudi experience with serotherapy. Toxicon 1994; 32: 1019–1026
- Sofer S, Shahak E, Gueron M. Scorpion envenomation and antivenom therapy. J Pediatr 1994; 124: 973–978
- Bawaskar H S, Bawaskar P H. Treatment of cardiovascular manifestations of human scorpion envenoming: Is serotherapy essential?. J Trop Med Hyg 1991; 94: 156–158
- Gueron M, Margulis G, Ilia R, Sofer S. The management of scorpion envenomation 1993. Toxicon 1993; 31: 1071–1083
- Ismail M. Serotherapy of the scorpion envenoming syndrome is irrationally convicted without trial. Toxicon 1993; 31: 1077–1083
- De Rezende N A, Dias M B, Campolina D, Chavez-Olortegui C, Diniz C R, Amaral C F. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions. Am J Trop Med Hyg 1995; 52: 277–280
- Goyffon M, Vachon M, Broglio N. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon 1982; 20: 337–344
- Ismail M, Abdullah M E, Morad A M, Ageel A M. Pharmacokinetics of 125I-labelled venom from the scorpion Androctonus amoreuxi (Aud. and Sav.). Toxicon 1980; 18: 301–308
- Ismail M, Shibl A M, Morad A M, Abdullah M E. Pharmacokinetics of 125I-labelled antivenom to the venom from the scorpion Androctonus amoreuxi. Toxicon 1983; 21: 47–56
- Tarasiuk A, Khvatskin S, Sofer S. Effects of antivenom serotherapy on hemodynamic pathophysiology in dogs injected with L. quinquestriatus scorpion venom. Toxicon 1998; 36: 963–971
- Amitai Y, Mines Y, Aker M, Goitein K. Scorpion sting in children. A review of 51 cases. Child Pediatr (Phila) 1985; 24: 136–140
- Hershkovich Y, Elitsnr Y, Margolis C. Criteria map of scorpion envenomation in the Neguev. Toxicon 1985; 45: 979–986
- Gwee M C, Cheah L S, Gopalakrishnakone P. Involvement of the L-arginine-nitric oxide synthase pathway in the relaxant responses of the rat isolated anococcygenus muscle to a scorpion (Leiurus quinquestriatus quinquestriatus) venom. Toxicon 1995; 33: 1141–1150
- Freire-Maia L, Dematos I M. Heparin or a PAF antagonist (Bon-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. Toxicon 1993; 31: 1207–1210
- Sofer S, Gueron M, White R M, Lifshitz M, Apte R N. Interleukin-6 release following scorpion sting in children. Toxicon 1996; 34: 389–392